Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.25 HKD | -3.04% | +0.83% | -19.23% |
26/04 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04/04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.36B | - | |||||
111B | ||||||
105B | ||||||
22.34B | - | |||||
21.93B | - | |||||
18.59B |
- Stock Market
- Equities
- 9995 Stock
- Charts RemeGen Co., Ltd.
- Sector Chart